Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132177) titled 'A Multicenter, Prospective Clinical Study of the FJ-PAML-26 Regimen for the Treatment of Newly Diagnosed Pediatric Acute Myeloid Leukemia' on Sept. 10.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Fujian Medical University Union Hospital
Condition:
pediatric acute myeloid leukemia
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-15
Target Sample Size: Experimental group:176;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=342084
Published by HT Digital Content Services with permission from ...